ADHD Medication Efficacy in Autism Comorbidity

Plain-language summary

There is limited and mixed evidence regarding the effectiveness and safety of ADHD medications specifically for individuals with both ADHD and autism spectrum disorder. More research is needed to provide clear guidance, as some studies address related topics but not the direct question. Therefore, no definitive conclusions about medication efficacy or safety can be drawn from the provided research.

Key findings

• One study suggests guidelines for pharmacological treatment of co-occurring psychiatric symptoms in autism, indicating a need for careful consideration of medication in this population.
• Another study focuses on distinguishing ADHD, autism, and their co-occurrence based on self-reported symptoms, highlighting the complexity of diagnosis.
• It is known that many individuals with autism spectrum disorder also have other psychiatric conditions, which complicates treatment approaches.
• The provided research does not directly address the effectiveness or safety of ADHD medications when ADHD and autism spectrum disorder co-occur.

Studies cited (8)

1. Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses — Hossain MM, Khan N, Sultana A (2020, Psychiatry research, systematic-review)

   DOI: 10.1016/j.psychres.2020.112922

2. Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study — Liew Z, Ritz B, Virk J (2016, Autism research : official journal of the International Society for Autism Research, observational)

   DOI: 10.1002/aur.1591

3. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms — Manter MA, Birtwell KB, Bath J (2025, BMC medicine, other)

   DOI: 10.1186/s12916-024-03814-0 PMCID: PMC11705908

4. Self-reported symptoms of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and affective lability in discriminating adult ADHD, ASD and their co-occurrence — Pehlivanidis A, Kouklari EC, Kalantzi E (2025, BMC psychiatry, other)

   DOI: 10.1186/s12888-025-06841-0 PMCID: PMC12007368

5. Differential diagnosis between autism spectrum disorder and other developmental disorders with emphasis on the preschool period — de Lima TA, Zuanetti PA, Nunes MEN (2023, World journal of pediatrics : WJP, other)

   DOI: 10.1007/s12519-022-00629-y

6. Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women — Young S, Adamo N, Ásgeirsdóttir BB (2020, BMC psychiatry, other)

   DOI: 10.1186/s12888-020-02707-9 PMCID: PMC7422602

7. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus — Young S, Hollingdale J, Absoud M (2020, BMC medicine, other)

   DOI: 10.1186/s12916-020-01585-y PMCID: PMC7247165

8. What have we learnt about the causes of ADHD? — Thapar A, Cooper M, Eyre O (2013, Journal of child psychology and psychiatry, and allied disciplines, other)

   DOI: 10.1111/j.1469-7610.2012.02611.x PMCID: PMC3572580